Impact News +++ EVOTEC - Das nächste Opfer der Shortseller-Krise (GodmodeTrader) +++ EVOTEC Aktie -3,72%

AURIS MEDICAL Aktie

 >AURIS MEDICAL Aktienkurs 
2.56 EUR    (Tradegate)
Ask: 2.60 EUR / 1200 Stück
Bid: 2.52 EUR / 1200 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 8 bis 22 Uhr!
>AURIS MEDICAL Performance
1 Woche: +23,4%
1 Monat: +10,0%
3 Monate: +260,4%
6 Monate: +208,8%
1 Jahr: +101,5%
laufendes Jahr: +24,5%
>AURIS MEDICAL Aktie
Name:  AURIS MEDICAL HLDG SF-,01
Land:  Hong Kong (China)
Sektor:  Gesundheit
ISIN/ Wkn:  BMG070252017 / A2PJN3
Symbol/ Ticker:  2QAA (Frankfurt) / EARS (NASDAQ)
Kürzel:  FRA:2QAA, 2QAA.F, 2QAA:GR, NASDAQ:EARS
Index:  -
Webseite:  https://aurismedical.com/
Marktkapitalisierung:  -
Umsatz:  -
EBITDA:  -
Gewinn je Aktie:  -1.09 EUR
Schulden:  -
Liquide Mittel:  -
Umsatz-/ Gewinnwachstum:  - / -
KGV/ KGV lG:  - / -
KUV/ KBV/ PEG:  - / - / -
Gewinnm./ Eigenkapitalr.:  - / -84.67%
Dividende je Aktie:  -
Dividendenrendite/ -schätzung:  - / -
Insiderhandel:  -
Suchwörter:  AURIS MEDICAL, AURIS MED
Letzte Datenerhebung:  25.01.21
>AURIS MED Eigentümer
Aktien: 11.42 Mio. St.
f.h. Aktien: 6.74 Mio. St.
Insider Eigner: 6.05%
Instit. Eigner: 0.48%
Leerverk. Aktien: 0.41%
>AURIS MED Peer Group

 
15.12.20 - 14:33
 Auris Medical Provides Business Update (GlobeNewswire EN)
 
Hamilton, Bermuda, December 15, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders, toda...
07.12.20 - 22:12
 Auris Medical Holding to Present at the 13th Annual LD Micro Main Event Conference (GlobeNewswire EN)
 
Hamilton, Bermuda, December 7, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders, today...
07.12.20 - 03:00
 Week Ahead In Pharma: FDA Decisions, ASH Data Readouts (LPCN, SYRS, MBIO, CYAD...) (RTTNews)
 
In the just concluded week, Auris Medical Holding Ltd. (EARS) made the biggest weekly advance, gaining over 180%, thanks to positive in vitro efficacy data of AM-301 in protecting against SARS-CoV-2 infection. Now, let's take a look at some of the s...
02.12.20 - 17:07
 Catabasis Pharmaceuticals, iBio leads healthcare gainers; Ovid Therapeutics, Auris Medical among major losers (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
02.12.20 - 15:01
 Auris Medical prices $8M direct equity offering, stock -22% (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
02.12.20 - 14:48
 Auris Medical Holding Ltd. Prices $8,000,000 Common Shares Offering Priced At-the-Market (GlobeNewswire EN)
 
Hamilton, Bermuda, December 2, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS) (“Auris” or the “Company”), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology a...
02.12.20 - 08:16
 OVID Plunges, VNDA′s Hetlioz Scores Another FDA Nod, Auris Investors Smile Ear To Ear (RTTNews)
 
Today's Daily Dose brings you news about OVID'S Angelman syndrome trial failure, the FDA expanding approval of Vanda's Hetlioz to Smith-Magenis Syndrome, the 455% jump in stock price of Auris Medical, Histogen's phase Ib/IIa clinical trial result...
01.12.20 - 19:31
 Why Auris Medical′s Stock Is Trading Higher By 445% Today (Benzinga)
 
Auris Medical (NASDAQ: EARS) shares are ripping higher on Tuesday after the company reported positive efficacy data for its AM-301 in protecting against Sars COVID-19 infections. read more...
01.12.20 - 17:22
 Auris Medical Holding leads healthcare gainers; Cocrystal Pharma, Apollo Endosurgery among losers (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
01.12.20 - 16:07
 Auris Medical soars after AM-301 shows encouraging preclinical action against SARS-CoV-2 infection (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
01.12.20 - 15:03
 Auris Medical Reports Positive In vitro Efficacy Data for AM-301 in Protecting Against Sars-CoV-2 Infection (GlobeNewswire EN)
 
Hamilton, Bermuda, December 1, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders, today...
20.11.20 - 15:12
 Auris Medical Launches Website for AM-301-focused Subsidiary, Altamira Medica (GlobeNewswire EN)
 
Hamilton, Bermuda, November 20, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology, rhinology and allergy and CNS disorders, toda...
13.10.20 - 16:52
 Why Auris Medical′s Stock Is Trading Higher Today (Benzinga)
 
Auris Medical (NASDAQ: EARS) shares are trading higher on Tuesday as traders seem to be mistaking the company for Auris Health, which was acquired by Johnson & Johnson (NYSE: JNJ). read more...
13.10.20 - 15:28
 Auris Medical launches second part of mid-stage study with AM-125 in vertigo (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
13.10.20 - 15:03
 Auris Medical Announces Initiation of Part B of TRAVERS Phase 2 Study with AM-125 in Vertigo (GlobeNewswire EN)
 
Hamilton, Bermuda, October 13, 2020 – Auris Medical Holding Ltd. (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and central nervous system disorders, today ann...
17.09.20 - 20:01
 Auris Medical Holding Ltd. 2020 Q2 - Results - Earnings Call Presentation (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
17.09.20 - 19:31
 Auris Medical Holding Ltd. (EARS) CEO Thomas Meyer on Q2 2020 Results - Earnings Call Transcript (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
17.09.20 - 17:56
 Auris Medical Holding Ltd.: 6-K/A Report (SEC Filing)
 
AMENDMENT TO FORM 6-K...
17.09.20 - 15:34
 Auris Medical +5% on 1H results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
17.09.20 - 14:28
 Auris Medical reports 1H results (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
>Zitat des Tages: Ich halte nichts von Weltranglisten von Unternehmen in Zeitungen. Das zeigt nur, daß die Sportredaktionen stärker sind als die Wirtschaftsredaktionen. - Dr. Heinrich Treichl
Partner:    >Tradegate Börse | >TraderFox Handelssignale | >Heibel-Ticker Börsenbrief | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf Twitter | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!